| Authors | Kamiar Mireskandari, Megan E Collins, Nasrin Tehrani |
| Journal | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
(Can J Ophthalmol)
Vol. 50
Issue 6
Pg. 409-12
(Dec 2015)
ISSN: 1715-3360 [Electronic] England |
| PMID | 26651298
(Publication Type: Journal Article, Review)
|
| Chemical References |
- Angiogenesis Inhibitors
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Bevacizumab
|
| Topics |
- Angiogenesis Inhibitors
(adverse effects, therapeutic use)
- Bevacizumab
(adverse effects, therapeutic use)
- Humans
- Infant
- Infant, Newborn
- Informed Consent
- Intravitreal Injections
- Practice Guidelines as Topic
- Retinopathy of Prematurity
(drug therapy)
- Risk Factors
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
|
